The overwhelming federal nature of this subject is apparent,” the lawsuit alleges. “States are not free to tinker with ...

And if you're looking for top dividend-paying companies to put your money in right now, let's consider two excellent ...

Researchers found significant variability in the dissolution profiles extended-release methylphenidate formulations across manufacturers.

Legend Biotech announced its Q2 earnings, reporting $439m of revenues for its only commercial product, the cell therapy ...

The state of Maine is being sued by a pharmaceutical company over its discount drug program. Novartis, a New Jersey-based company, is seeking to end Maine’s regulation of the 340B Drug Pricing Program ...

Drugs to treat attention deficit hyperactivity disorder were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind.

Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...

Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...

The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.

Medulla has worked with global companies including Pfizer, Novartis, Ferring, Mylan, Braintap, Bayer, Kenvue, and more.

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...

Novartis Pharmaceuticals filed a lawsuit against the State of Rhode Island seeking to block the enforcement of a new state law regulating the little-known, but big impact federal 340B Drug Pricing ...